mesoblast

Dr. Teresa Montagut Appointed as Clinical Development and Medical Affairs Head at Mesoblast

March 11, 2026 19:21 ET  | Source: Mesoblast Limited NEW YORK, March 11, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO;…

2 weeks ago

Mesoblast Announces Changes to Board of Directors’ Leadership Roles

January 01, 2026 18:02 ET  | Source: Mesoblast Limited NEW YORK, Jan. 01, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO;…

3 months ago

Mesoblast Retires Senior Debt with Non-Dilutive, Lower Cost, Five-Year Credit Line

December 29, 2025 18:57 ET  | Source: Mesoblast Limited Mesoblast has option to draw down up to US$125 million by…

3 months ago